Ruisin Hospital
Zhu Yunpeng
The goal of this pilot trial is to to evaluate the preliminary effect of oral colchicine therapy on graft outcomes in patients underwent primary isolated CABG. The main questions it aims to answer is: 1. Whether the oral colchicine therapy may reduce the failure outcome of grafts after CABG. 2. Whether it is feasible to construct a muticenter powered trial to test the superiority hypothesis. Researchers will compare colchicine to none to see if colchicine works. Participants will 1. Take oral colchicine (0.5mg daily) therapy for 12 months after CABG. 2. Clinical follow-up at Month 1, 6, and 12 after CABG. 3. Protocol-driven CCTA at Week 1 and Month 12 after CABG.
CABG
Graft Failure
Colchicine
Colchicine
PHASE4
Study Type : | INTERVENTIONAL |
Estimated Enrollment : | 100 participants |
Masking : | SINGLE |
Primary Purpose : | TREATMENT |
Official Title : | A Single Center Pilot Trial of Preliminary Effect of Colchicine on Graft Failure in Patients Underwent CABG |
Actual Study Start Date : | 2025-07 |
Estimated Primary Completion Date : | 2027-06 |
Estimated Study Completion Date : | 2027-12 |
Information not available for Arms and Intervention/treatment
Ages Eligible for Study: | 18 Years |
Sexes Eligible for Study: | ALL |
Accepts Healthy Volunteers: |
Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.
Not yet recruiting
Ru I entered hospital Shanghai J i AO tong university school of medicine
Shanghai, China,